摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(2-chloro-phenylsulfanylmethyl)-isoxazole-3-carboxylic acid hydroxyamide | 823220-09-3

中文名称
——
中文别名
——
英文名称
5-(2-chloro-phenylsulfanylmethyl)-isoxazole-3-carboxylic acid hydroxyamide
英文别名
3-Isoxazolecarboxamide, 5-[[(2-chlorophenyl)thio]methyl]-N-hydroxy-;5-[(2-chlorophenyl)sulfanylmethyl]-N-hydroxy-1,2-oxazole-3-carboxamide
5-(2-chloro-phenylsulfanylmethyl)-isoxazole-3-carboxylic acid hydroxyamide化学式
CAS
823220-09-3
化学式
C11H9ClN2O3S
mdl
——
分子量
284.723
InChiKey
VCZVWKIHPCHVNV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    101
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:cf77748844d8ff1a306981009c918f3c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] ISOXAZOLES AS PEPTIDE DEFORMYLASE INHIBITORS<br/>[FR] ISOXAZOLES UTILISES COMME INHIBITEURS DE PEPTIDE DEFORMALYSE
    申请人:ARPIDA AS
    公开号:WO2005026133A1
    公开(公告)日:2005-03-24
    Isoxazole compounds of formula (I) and pharmaceutically acceptable salts or esters thereof are peptide deformylase inhibitors useful in the treatment or prevention of infections and other disease in which peptide deformylases are involved, especially in the treatment of bacterial and parasitic infections, for example infections fully or partly caused by microorganisms belonging to Staphylococcus, Enterococcus, Streptococcus, Haemophilus, Moraxella, Escherichia, Mycobacterium, Mycoplasma, Pseudomonas, Chlamydia, Rickettsia, Klebsiella, Shigella, Salmonella, Bordetella, Clostridium, Helicobacter, Campylobacter, Legionella or Neisseria.
    式(I)的异噁唑化合物及其药学上可接受的盐或酯是肽变形酶抑制剂,在治疗或预防涉及肽变形酶的感染和其他疾病方面非常有用,特别是在治疗细菌和寄生虫感染方面,例如完全或部分由属于葡萄球菌、肠球菌、链球菌、流感嗜血杆菌、嗜莫雷拉菌、大肠杆菌、分枝杆菌、支原体、假单胞菌、沙眼衣原体、立克次体、克雷伯菌、志贺氏菌、沙门氏菌、百日咳杆菌、梭菌、幽门螺杆菌、空肠弯曲菌、军团菌或莫拉氏菌等微生物引起的感染的治疗中。
  • ISOXAZOLES AS PEPTIDE DEFORMYLASE INHIBITORS
    申请人:Arpida A/S
    公开号:EP1664000A1
    公开(公告)日:2006-06-07
  • Isoxazoles as peptide deformylase inhibitors
    申请人:Cali Patrizia
    公开号:US20070043062A1
    公开(公告)日:2007-02-22
    Isoxazole compounds of formula (I) and pharmaceutically acceptable salts or esters thereof are peptide deformylase inhibitors useful in the treatment or prevention of infections and other disease in which peptide deformylases are involved, especially in the treatment of bacterial and parasitic infections, for example infections fully or partly caused by microorganisms belonging to Staphylococcus, Enterococcus, Streptococcus, Haemophilus, Moraxella, Escherichia, Mycobacterium, Mycoplasma, Pseudomonas, Chlamydia, Rickettsia, Klebsiella, Shigella, Salmonella, Bordetella, Clostridium, Helicobacter, Campylobacter, Legionella or Neisseria .
  • Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents
    作者:Patrizia Calí、Lars Nærum、Seema Mukhija、Anders Hjelmencrantz
    DOI:10.1016/j.bmcl.2004.09.087
    日期:2004.12
    A series of isoxazole-3-hydroxamic acid derivatives has been identified as a new class of small, nonpeptidic inhibitors of peptide deformylase (PDF). The synthesis, enzyme inhibition and preliminary investigation of the binding mode of this potential antibacterial compounds are reported. (C) 2004 Elsevier Ltd. All rights reserved.
查看更多